The Development of Early Childhood Obesity in Children Born Preterm
The Development of Early Childhood Obesity in Children Born Preterm
批准号:
9112267
负责人:
Sarah Keim
金额:
$7.48万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-22 至 2018-08-31
关键词:
3 year oldAgeAnxietyAttentionBirthBody mass indexCardiovascular DiseasesCaringChildClinicalCoupledDataData SetDevelopmentDiagnosisElderlyEnsureEnvironmentEpidemicEvidence based interventionFamilyFutureGoalsGrowthIndividualInterventionKnowledgeLengthLifeLongitudinal StudiesLow Birth Weight InfantMeasuresMedicalMedical RecordsMental DepressionMissionModelingNatureNeonatalObesityOverweightPatientsPediatric HospitalsPopulationPremature BirthPremature InfantPrevalencePreventionPrevention strategyProviderPublic HealthQuality of lifeRecords ControlsResearchRiskSamplingSmall for Gestational Age InfantStatistical MethodsStressTestingTimeUnited States National Institutes of HealthVisitWeightbasebody systemburden of illnessclinical careclinical practicecohortcostearly childhoodevidence baseinnovationkindergartenobesity in childrenobesity preventionobesogenicpatient populationpediatric patientsprematurepreventprogramspsychosocialpublic health relevanceresearch clinical testingscreeningsocialsocioeconomicstool
中文摘要
英文摘要
DESCRIPTION (provided by applicant): Facilitating catch-up growth and preventing growth faltering is a major component of clinical care for children born preterm to at least age two. However, our preliminary data suggest that obesity is a major, under- recognized problem in the preterm population and likely emerges differently than for children born at term. Obesity has harmful consequences for children born preterm, far greater than the consequences for children born at term. Without knowledge to fill gaps about the extent, nature, and timing of obesity development and how consistently obesity is recognized in clinical care, tailored prevention strategies cannot be developed to help clinicians and families promote adequate growth while preventing excess growth among preterm children. The long-term goal, which will be the subject of a subsequent R01 application, is to develop evidence-based strategies tailored to preterm children to guide clinicians and families in preventing overweight and obesity. The objective of the study proposed in this R03 application, which is the next step towards that goal, is to apply cutting edge statistical methods to determine the prevalence and timing of the development of overweight and obesity in early childhood among preterm children, as compared to term children, to identify optimal intervention windows, and to document the extent of under-recognition of obesity during clinical care in a longitudinal sample of more than 16,000 children. The central hypothesis is: as compared to children born at term, growth trajectories will differ most especially before age 3 among preterm children but overweight and obesity will be nearly as prevalent by ages 4-6, and that obese children born preterm will be less likely to have an obesity diagnosis. The hypothesis was formulated based on data from historic low birth weight cohorts and our preliminary data. The rationale for the proposed study is to support the development of evidence-based interventions targeting sensitive periods to prevent overweight and obesity in children born preterm. The hypothesis will be tested by pursuing two specific aims: 1) Identify critical windows for obesity prevention by characterizing growth trajectories from birth to age 6 for children born preterm, and contrasting these with trajectories for children
born at term, to compare the prevalence and timing of the development of overweight and obesity, and 2) Determine the extent of obesity under-diagnosis among children born preterm, as compared to children born at term. The approach will be a longitudinal study of more than 16,000 children from birth to age 6, patients of primary and subspecialty care providers at a major free-standing children's hospital. The proposed research is innovative because it will apply state-of-the-art analytic tools to model growth trajectories in a modern sample, using a detailed, research-ready longitudinal growth dataset based in a very large pediatric patient population, including children born preterm and at term, with an average of more than 13 measures before age six. The proposed research is significant because it is the next step in devising strategies to help clinicians and families promote healthy growth in children born preterm while preventing obesity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Environmental Influences on Child Health Outcomes (ECHO) and Pregnancy in Ohio
-
批准号:10746498
-
项目类别:
-
资助金额:$132.58万
-
财政年份:2023
-
负责人:Sarah Keim
-
依托单位:
Long-term Effects and Safety of DHA Supplementation in Toddlerhood for Children born Preterm
-
批准号:10226056
-
项目类别:
-
资助金额:$61.73万
-
财政年份:2020
-
负责人:Sarah Keim
-
依托单位:
Long-term Effects and Safety of DHA Supplementation in Toddlerhood for Children born Preterm - Administrative Supplement
-
批准号:10727669
-
项目类别:
-
资助金额:$15.6万
-
财政年份:2020
-
负责人:Sarah Keim
-
依托单位:
Long-term Effects and Safety of DHA Supplementation in Toddlerhood for Children born Preterm
-
批准号:10650351
-
项目类别:
-
资助金额:$59.04万
-
财政年份:2020
-
负责人:Sarah Keim
-
依托单位:
Long-term Effects and Safety of DHA Supplementation in Toddlerhood for Children born Preterm
-
批准号:10012322
-
项目类别:
-
资助金额:$66.18万
-
财政年份:2020
-
负责人:Sarah Keim
-
依托单位:
Long-term Effects and Safety of DHA Supplementation in Toddlerhood for Children born Preterm
-
批准号:10443726
-
项目类别:
-
资助金额:$60.33万
-
财政年份:2020
-
负责人:Sarah Keim
-
依托单位:
Fatty acid supplements alter biological signatures in children with Autism Spectrum Disorder
-
批准号:10222888
-
项目类别:
-
资助金额:$34.66万
-
财政年份:2017
-
负责人:Sarah Keim
-
依托单位:
Fatty acid supplements alter biological signatures in children with Autism Spectrum Disorder
-
批准号:10266170
-
项目类别:
-
资助金额:$37.69万
-
财政年份:2017
-
负责人:Sarah Keim
-
依托单位:
Fatty acid supplements alter biological signatures in children with Autism Spectrum Disorder
-
批准号:10480779
-
项目类别:
-
资助金额:$40.05万
-
财政年份:2017
-
负责人:Sarah Keim
-
依托单位:
Development and Evaluation of New Breastfeeding Questions Applicable to Multiple National Surveys
-
批准号:9159393
-
项目类别:
-
资助金额:$7.48万
-
财政年份:2016
-
负责人:Sarah Keim
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: